Sep 2026· SARPS: Journal of Advanced Research in Plant Science· 0 citations· 9 references
TL;DR
The integrated synthetic, kinetic, and biological findings demonstrate the potential of oxindole derivatives as promising lead molecules for developing next-generation antidiabetic agents with improved efficacy and molecular selectivity.
Abstract
The continuous rise in the global prevalence of type 2 diabetes mellitus has intensified the search for effective α-glucosidase inhibitors capable of controlling postprandial hyperglycemia with improved therapeutic efficacy and reduced adverse effects. Oxindole represents a privileged heterocyclic scaffold exhibiting remarkable structural diversity and broad pharmacological potential, making it an attractive candidate for antidiabetic drug discovery. This study focuses on the rational synthesis of novel oxindole derivatives, comprehensive structural characterization, evaluation of reaction kinetics, and investigation of their α-glucosidase inhibitory activities. The synthesized compounds were characterized using FT-IR, 1H NMR, 13C NMR, and HRMS techniques to confirm their molecular structures. Enzyme inhibition assays were conducted to determine inhibitory potency, while kinetic analyses were performed to elucidate the inhibition mechanism and enzyme–ligand interactions. The influence of structural modifications on biological activity was examined through structure–activity relationship analysis, highlighting the contribution of different substituents toward enhanced enzyme inhibition. The integrated synthetic, kinetic, and biological findings demonstrate the potential of oxindole derivatives as promising lead molecules for developing next-generation antidiabetic agents with improved efficacy and molecular selectivity.
Recent advances in oxadiazole derivatives as α-glucosidase and α-amylase inhibitors are summarized, with emphasis on structure activity relationships (SAR), molecular interactions, and mechanisms of enzyme inhibition.
Anuradha Mehra, Amit Mittal· Drug metabolism reviews (Sof...· 0 citations
These integrated experimental and computational results demonstrate that the polyhydroquinoline scaffold represents a promising platform for developing next-generation antidiabetic therapeutics with enhanced efficacy and favorable safety profiles.
Sultan Muhammad, A. Latif, Aftab Alam et al.· Future Medicinal Chemistry· 0 citations
The combined experimental and computational results demonstrate significant structure-activity relationships within the bis-oxadiazole scaffold, identifying compound 10 as a promising lead candidate for further optimization as a dual enzyme inhibitor for diabetes management.
Shoaib Khan, Tayyiaba Iqbal, B. N. Murtaza et al.· Future Medicinal Chemistry· 0 citations
Overall, the synthesized imidazole derivatives displayed promising in silico and in vitro antidiabetic potential, supporting their development as leads for T2DM therapy.
Sanjana Mareguddi, Prabitha Prabhakaran, Ammar Abdul Razzak Mahmood et al.· Indian Journal of Biochemist...· 0 citations
The oxindole-pyrrole-piperazine scaffold represents a promising template to find α-glucosidase inhibitors and elucidated the detailed binding mode of OPP-11 on α-glucosidase.
Baorong Guo, I. Ginjom, Zhen Liu et al.· Arabian Journal of Chemistry· 0 citations
Nine saturated anacardic acid derivatives were synthesized, well-characterized, and evaluated for their inhibitory activity against AG, finding 10 to be a potent α-glucosidase inhibitor with an IC50 of 0.24 µM, significantly surpassing the reference antidiabetic drug acarbose.
Van-Can Pham, T. Aree, Aamir Aman et al.· Medicinal Chemistry Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.